These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 16279710)

  • 1. [Osteopontin receptors and signal transduction].
    Yokosaki Y; Higashikawa F
    Nihon Rinsho; 2005 Oct; 63 Suppl 10():613-7. PubMed ID: 16279710
    [No Abstract]   [Full Text] [Related]  

  • 2. [Functional domain and its receptor of osteopontin].
    Katagiri YU; Uede T
    Seikagaku; 1998 Apr; 70(4):253-64. PubMed ID: 9617217
    [No Abstract]   [Full Text] [Related]  

  • 3. CD44 variants but not CD44s cooperate with beta1-containing integrins to permit cells to bind to osteopontin independently of arginine-glycine-aspartic acid, thereby stimulating cell motility and chemotaxis.
    Katagiri YU; Sleeman J; Fujii H; Herrlich P; Hotta H; Tanaka K; Chikuma S; Yagita H; Okumura K; Murakami M; Saiki I; Chambers AF; Uede T
    Cancer Res; 1999 Jan; 59(1):219-26. PubMed ID: 9892210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Integrin signal transduction via FAK in osteoblasts--early differentiation triggered by osteopontin].
    Nemoto A; Uemura T
    Seikagaku; 1999 Feb; 71(2):140-5. PubMed ID: 10200608
    [No Abstract]   [Full Text] [Related]  

  • 5. Intracellular osteopontin is an integral component of the CD44-ERM complex involved in cell migration.
    Zohar R; Suzuki N; Suzuki K; Arora P; Glogauer M; McCulloch CA; Sodek J
    J Cell Physiol; 2000 Jul; 184(1):118-30. PubMed ID: 10825241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Differentiation and function of bone cells induced by bone matrix proteins: osteopontin in bone remodeling].
    Uemura T; Nemoto A; Deng HY
    Tanpakushitsu Kakusan Koso; 1999 Feb; 44(2):143-8. PubMed ID: 10047731
    [No Abstract]   [Full Text] [Related]  

  • 7. The osteopontin - CD44 pathway is superfluous for the development of autoimmune myocarditis.
    Abel B; Kurrer M; Shamshiev A; Marty RR; Eriksson U; Günthert U; Kopf M
    Eur J Immunol; 2006 Feb; 36(2):494-9. PubMed ID: 16402410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-V-dependent outside-in signaling is required for the regulation of CD44 surface expression, MMP-2 secretion, and cell migration by osteopontin in human melanoma cells.
    Samanna V; Wei H; Ego-Osuala D; Chellaiah MA
    Exp Cell Res; 2006 Jul; 312(12):2214-30. PubMed ID: 16631740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Osteopontin and its modulators].
    Noda M; Chung CR; Koyama Y
    Nihon Rinsho; 2005 Oct; 63 Suppl 10():641-2. PubMed ID: 16279716
    [No Abstract]   [Full Text] [Related]  

  • 10. Colocalization of intracellular osteopontin with CD44 is associated with migration, cell fusion, and resorption in osteoclasts.
    Suzuki K; Zhu B; Rittling SR; Denhardt DT; Goldberg HA; McCulloch CA; Sodek J
    J Bone Miner Res; 2002 Aug; 17(8):1486-97. PubMed ID: 12162503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival.
    Denhardt DT; Noda M; O'Regan AW; Pavlin D; Berman JS
    J Clin Invest; 2001 May; 107(9):1055-61. PubMed ID: 11342566
    [No Abstract]   [Full Text] [Related]  

  • 12. [Inhibition of cellular adhesion and invasion in gliomas].
    Sasaki H; Yoshida K
    Nihon Rinsho; 2005 Sep; 63 Suppl 9():68-73. PubMed ID: 16201502
    [No Abstract]   [Full Text] [Related]  

  • 13. [Osteopontin].
    Suzuki K
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():145-9. PubMed ID: 15035114
    [No Abstract]   [Full Text] [Related]  

  • 14. Interaction between CD44 and osteopontin as a potential basis for metastasis formation.
    Weber GF; Ashkar S; Cantor H
    Proc Assoc Am Physicians; 1997 Jan; 109(1):1-9. PubMed ID: 9010911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autocrine activation of an osteopontin-CD44-Rac pathway enhances invasion and transformation by H-RasV12.
    Teramoto H; Castellone MD; Malek RL; Letwin N; Frank B; Gutkind JS; Lee NH
    Oncogene; 2005 Jan; 24(3):489-501. PubMed ID: 15516973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overcoming obstacles to metastasis--defenses against host defenses: osteopontin (OPN) as a shield against attack by cytotoxic host cells.
    Denhardt DT; Chambers AF
    J Cell Biochem; 1994 Sep; 56(1):48-51. PubMed ID: 7528752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteopontin is an autocrine mediator of hepatocyte growth factor-induced invasive growth.
    Medico E; Gentile A; Lo Celso C; Williams TA; Gambarotta G; Trusolino L; Comoglio PM
    Cancer Res; 2001 Aug; 61(15):5861-8. PubMed ID: 11479227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of osteopontin and its ligand, CD44, in the spinal cords of Lewis rats with experimental autoimmune encephalomyelitis.
    Kim MD; Cho HJ; Shin T
    J Neuroimmunol; 2004 Jun; 151(1-2):78-84. PubMed ID: 15145606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Osteopontin in rheumatoid arthritis].
    Saeki Y
    Nihon Rinsho; 2005 Oct; 63 Suppl 10():627-31. PubMed ID: 16279713
    [No Abstract]   [Full Text] [Related]  

  • 20. [Osteopontin and arthritis].
    Noda M; Yumoto K; Morinobu M; Tsuji K; Nifuji A
    Nihon Rinsho; 2003 May; 61(5):887-90. PubMed ID: 12755020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.